New Key Statistics Module, Z-Score and F-Score
NAS:BNTC Key Ratios
| Market Cap $ M | 19.26 |
| Enterprise Value $ M | -2.06 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.24 |
| Price/Sales | 200.81 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -10.95 |
| Beneish M-Score | -4.14 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.09 |
| EV-to-EBITDA | 0.10 |
| PEG | -- |
| Shares Outstanding M | 2.59 |
| Net Margin (%) | -35,754.10 |
| Operating Margin % | -35,560.66 |
| Pre-tax Margin (%) | -35,754.10 |
| Quick Ratio | 3.62 |
| Current Ratio | 3.62 |
| ROA % (ttm) | -149.39 |
| ROE % (ttm) | -210.98 |
| ROIC % (ttm) | -1,477.46 |
| Dividend Yield % | -- |
| Altman Z-Score | -12.54 |
BNTC Number of Guru Trades
BNTC Volume of Guru Trades
Gurus Latest Trades with NAS:BNTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BNTC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Benitec Biopharma Inc Insider Transactions
No Available Data
News about NAS:BNTC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers